Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
Operating Expenses | 7,840 | 9,909 | 8,110 | 4,034 | 3,121 |
Operating Income | -7,840 | -9,909 | -8,110 | -4,034 | -3,121 |
Interest Expense | 0 | 0 | -727 | -28 | -3 |
Other Income | 222 | 212 | 1,433 | 238 | 288 |
Pre-tax Income | -7,618 | -9,697 | -5,950 | -3,768 | -2,830 |
Net Income Continuous | -7,618 | -9,697 | -5,950 | -3,768 | -2,830 |
Net Income | $-7,618 | $-9,697 | $-5,950 | $-3,768 | $-2,830 |
EPS Basic Total Ops | -0.39 | -43.37 | -8.74 | -11.92 | -103.19 |
EPS Basic Continuous Ops | -0.39 | -4.35 | -10.40 | -6.89 | -5.61 |
EPS Diluted Total Ops | -0.39 | -43.37 | -8.74 | -11.92 | -103.19 |
EPS Diluted Continuous Ops | -0.39 | -4.35 | -10.40 | -6.89 | -5.61 |
EBITDA(a) | $-7,803 | $-9,901 | $-8,106 | $-4,030 | $-3,121 |